| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.6 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.6 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.6 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |